2-methyl-6-(6-methyl-2-pyridinyl)-1H-benzimidazole;6-(6-methyl-2-pyridinyl)-1H-benzimidazole;5-(6-methyl-2-pyridinyl)-3H-1-benzofuran-2-one;5-(6-methyl-2-pyridinyl)-3H-2-benzofuran-1-one;5-(6-methyl-2-pyridinyl)-3H-1,3-benzoxazol-2-one;5-(6-methyl-2-pyridinyl)-1,3-dihydroindol-2-one;6-(6-methyl-2-pyridinyl)-1,3-dihydroindol-2-one
C96H80N14O8 — CID 157224055
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-methyl-6-(6-methyl-2-pyridinyl)-1H-benzimidazole;6-(6-methyl-2-pyridinyl)-1H-benzimidazole;5-(6-methyl-2-pyridinyl)-3H-1-benzofuran-2-one;5-(6-methyl-2-pyridinyl)-3H-2-benzofuran-1-one;5-(6-methyl-2-pyridinyl)-3H-1,3-benzoxazol-2-one;5-(6-methyl-2-pyridinyl)-1,3-dihydroindol-2-one;6-(6-methyl-2-pyridinyl)-1,3-dihydroindol-2-one
2-methyl-6-(6-methyl-2-pyridinyl)-1H-benzimidazole;6-(6-methyl-2-pyridinyl)-1H-benzimidazole;5-(6-methyl-2-pyridinyl)-3H-1-benzofuran-2-one;5-(6-methyl-2-pyridinyl)-3H-2-benzofuran-1-one;5-(6-methyl-2-pyridinyl)-3H-1,3-benzoxazol-2-one;5-(6-methyl-2-pyridinyl)-1,3-dihydroindol-2-one;6-(6-methyl-2-pyridinyl)-1,3-dihydroindol-2-one (PubChem CID 157224055) has the molecular formula C96H80N14O8 and a molecular weight of 1557.79 g/mol. Its IUPAC name is 2-methyl-6-(6-methyl-2-pyridinyl)-1H-benzimidazole;6-(6-methyl-2-pyridinyl)-1H-benzimidazole;5-(6-methyl-2-pyridinyl)-3H-1-benzofuran-2-one;5-(6-methyl-2-pyridinyl)-3H-2-benzofuran-1-one;5-(6-methyl-2-pyridinyl)-3H-1,3-benzoxazol-2-one;5-(6-methyl-2-pyridinyl)-1,3-dihydroindol-2-one;6-(6-methyl-2-pyridinyl)-1,3-dihydroindol-2-one.
Molecular Properties
| Compound Name | 2-methyl-6-(6-methyl-2-pyridinyl)-1H-benzimidazole;6-(6-methyl-2-pyridinyl)-1H-benzimidazole;5-(6-methyl-2-pyridinyl)-3H-1-benzofuran-2-one;5-(6-methyl-2-pyridinyl)-3H-2-benzofuran-1-one;5-(6-methyl-2-pyridinyl)-3H-1,3-benzoxazol-2-one;5-(6-methyl-2-pyridinyl)-1,3-dihydroindol-2-one;6-(6-methyl-2-pyridinyl)-1,3-dihydroindol-2-one |
|---|---|
| PubChem CID | 157224055 |
| Molecular Formula | C96H80N14O8 |
| Molecular Weight | 1557.79 g/mol |
| Exact Mass | 1556.63 |
| IUPAC Name | 2-methyl-6-(6-methyl-2-pyridinyl)-1H-benzimidazole;6-(6-methyl-2-pyridinyl)-1H-benzimidazole;5-(6-methyl-2-pyridinyl)-3H-1-benzofuran-2-one;5-(6-methyl-2-pyridinyl)-3H-2-benzofuran-1-one;5-(6-methyl-2-pyridinyl)-3H-1,3-benzoxazol-2-one;5-(6-methyl-2-pyridinyl)-1,3-dihydroindol-2-one;6-(6-methyl-2-pyridinyl)-1,3-dihydroindol-2-one |
| SMILES | Cc1cccc(-c2ccc3c(c2)CC(=O)N3)n1.Cc1cccc(-c2ccc3c(c2)CC(=O)O3)n1.Cc1cccc(-c2ccc3c(c2)COC3=O)n1.Cc1cccc(-c2ccc3c(c2)NC(=O)C3)n1.Cc1cccc(-c2ccc3nc(C)[nH]c3c2)n1.Cc1cccc(-c2ccc3nc[nH]c3c2)n1.Cc1cccc(-c2ccc3oc(=O)[nH]c3c2)n1 |
| InChI | InChI=1S/C14H13N3.2C14H12N2O.2C14H11NO2.C13H11N3.C13H10N2O2/c1-9-4-3-5-12(15-9)11-6-7-13-14(8-11)17-10(2)16-13;1-9-3-2-4-12(15-9)10-5-6-13-11(7-10)8-14(17)16-13;1-9-3-2-4-12(15-9)10-5-6-11-8-14(17)16-13(11)7-10;1-9-3-2-4-13(15-9)10-5-6-12-11(7-10)8-17-14(12)16;1-9-3-2-4-12(15-9)10-5-6-13-11(7-10)8-14(16)17-13;1-9-3-2-4-11(16-9)10-5-6-12-13(7-10)15-8-14-12;1-8-3-2-4-10(14-8)9-5-6-12-11(7-9)15-13(16)17-12/h3-8H,1-2H3,(H,16,17);2*2-7H,8H2,1H3,(H,16,17);2*2-7H,8H2,1H3;2-8H,1H3,(H,14,15);2-7H,1H3,(H,15,16) |
| InChIKey | ATIHQPGAQDQWCV-UHFFFAOYSA-N |
| XLogP | 19.02 |
| TPSA | 304.39 Ų |
| H-Bond Donors | 5 |
| H-Bond Acceptors | 17 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 118 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1557.79 |
| LogP ≤ 5 | 19.02 |
| H-Bond Donors ≤ 5 | 5 |
| H-Bond Acceptors ≤ 10 | 17 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'phenol_ester', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 157224055 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.